> top > docs > PMC:7195088 > spans > 46225-47448 > annotations

PMC:7195088 / 46225-47448 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1395 89-97 Species denotes patients Tax:9606
1396 669-677 Species denotes patients Tax:9606
1397 723-731 Species denotes patients Tax:9606
1398 805-813 Species denotes patients Tax:9606
1399 1119-1129 Species denotes SARS-CoV-2 Tax:2697049
1400 167-176 Species denotes influenza Tax:11520
1401 212-221 Species denotes influenza Tax:11520
1402 1068-1076 Species denotes patients Tax:9606
1403 191-201 Chemical denotes umifenovir MESH:C086979
1404 422-433 Chemical denotes favipiravir MESH:C462182
1405 691-702 Chemical denotes favipiravir MESH:C462182
1406 742-752 Chemical denotes umifenovir MESH:C086979
1407 824-835 Chemical denotes favipiravir MESH:C462182
1408 80-88 Disease denotes COVID-19 MESH:C000657245
1409 660-668 Disease denotes COVID-19 MESH:C000657245
1410 714-722 Disease denotes COVID-19 MESH:C000657245
1411 874-883 Disease denotes mortality MESH:D003643
1412 1044-1058 Disease denotes critically ill MESH:D016638
1413 1059-1067 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T83 118-121 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T84 132-135 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T258 80-88 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T259 167-176 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T260 212-221 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T261 660-668 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T262 714-722 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T263 1059-1067 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T264 1119-1127 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T269 177-185 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T270 222-230 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T271 565-569 http://purl.obolibrary.org/obo/CLO_0008416 denotes peer
T272 565-569 http://purl.obolibrary.org/obo/CLO_0050081 denotes peer
T273 633-634 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T274 1102-1110 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T275 1139-1142 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T560 6-22 Chemical denotes antiviral agents http://purl.obolibrary.org/obo/CHEBI_22587
T561 102-113 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T562 132-156 Chemical denotes RNA polymerase inhibitor http://purl.obolibrary.org/obo/CHEBI_37416
T563 147-156 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T564 191-201 Chemical denotes umifenovir http://purl.obolibrary.org/obo/CHEBI_134730
T565 238-247 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T566 422-433 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T567 691-702 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T568 742-752 Chemical denotes umifenovir http://purl.obolibrary.org/obo/CHEBI_134730
T569 824-835 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T570 1092-1101 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T571 1170-1180 Chemical denotes ivermectin http://purl.obolibrary.org/obo/CHEBI_6078

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T14 222-237 http://purl.obolibrary.org/obo/GO_0061025 denotes membrane fusion

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T365 0-253 Sentence denotes Other antiviral agents currently being investigated in RCT for the treatment of COVID-19 patients are favipiravir, an RNA-dependent RNA polymerase inhibitor with anti-influenza activity, and umifenovir, and anti-influenza membrane fusion inhibitor [29].
T366 254-616 Sentence denotes Even though these two agents attracted important media attention in the last few months, and even though there were some favourable preliminary results, especially for favipiravir, released as preprints, we advocate caution in using these agents outside investigational studies until completion of the standard peer-review processes of the first released trials.
T367 617-1082 Sentence denotes For example, in a recent RCT comparing 120 COVID-19 patients treated with favipiravir versus 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir, but it is of note that the all-cause mortality was 0 in the entire study population, making it uncertain whether, if confirmed, these favourable results may be extrapolated to relevant survival endpoints in critically ill COVID-19 patients [30].
T368 1083-1223 Sentence denotes Finally, antiviral activity against SARS-CoV-2 in vitro has been recently reported for ivermectin, but clinical data are still lacking [31].

2_test

Id Subject Object Predicate Lexical cue
32360444-32147628-22369769 249-251 32147628 denotes 29
32360444-32251768-22369770 1219-1221 32251768 denotes 31